Clinical and immunological characteristics of newborn infants from mothers with cancers
- 作者: Makieva M.I1, Matveeva N.K1, Vanko L.V1, Tsoi T.A1, Zhukova A.S1, Shatalova E.A1, Polushkina E.S1, Averyanova M.V2, Timofeeva L.A1, Krechetova L.V1, Zubkov V.V1, Shmakov P.G1,3
-
隶属关系:
- National Medical Research Center of Obstetrics, Gynecology, and Perinatology named after V.I. Kulakov
- Pirogov Russian National Research Medical University
- Federal State Autonomous Educational Institution of Higher Education, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russia
- 期: 编号 11 (2017)
- 页面: 92-99
- 栏目: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/248083
- DOI: https://doi.org/10.18565/aig.2017.ll.92-99
- ID: 248083
如何引用文章
详细
全文:
作者简介
M. Makieva
National Medical Research Center of Obstetrics, Gynecology, and Perinatology named after V.I. Kulakov
Email: m_makieva@oparina4.ru
neonatologist, pediatrician, the head of the clinical work of the department of newborns
N. Matveeva
National Medical Research Center of Obstetrics, Gynecology, and Perinatology named after V.I. Kulakov
Email: matveeva_nk@mail.ru
candidate of biological science, senior researcher of clinical immunology laboratory
L. Vanko
National Medical Research Center of Obstetrics, Gynecology, and Perinatology named after V.I. Kulakov
Email: lvanko@mail.ru
doctor of medicine, professor, leading research worker of clinical immunology laboratory
T. Tsoi
National Medical Research Center of Obstetrics, Gynecology, and Perinatology named after V.I. Kulakov
Email: t_tsoy@oparina4.ru
neonatologist
A. Zhukova
National Medical Research Center of Obstetrics, Gynecology, and Perinatology named after V.I. Kulakov
Email: a_belyaeva@oparina4.ru
research worker of clinical immunology laboratory
E. Shatalova
National Medical Research Center of Obstetrics, Gynecology, and Perinatology named after V.I. Kulakov
Email: e_shatalova@oparina4.ru
neonatologist
E. Polushkina
National Medical Research Center of Obstetrics, Gynecology, and Perinatology named after V.I. Kulakov
Email: e_polushkina@oparina4.ru
candidate of medicine sciences, obstetrician-gynecologist
M. Averyanova
Pirogov Russian National Research Medical University
Email: marisha@mail.ru
6-year student
L. Timofeeva
National Medical Research Center of Obstetrics, Gynecology, and Perinatology named after V.I. Kulakov
Email: leilatimofeeva@mail.ru,l_timofeeva@oparina4.ru
candidate of medicine sciences, the head of the department of newborns
L. Krechetova
National Medical Research Center of Obstetrics, Gynecology, and Perinatology named after V.I. Kulakov
Email: k_l_v_@mail.ru
candidate of medicine sciences, head of clinical immunology laboratory
V. Zubkov
National Medical Research Center of Obstetrics, Gynecology, and Perinatology named after V.I. Kulakov
Email: v_zubkov@oparina4.ru
Doctor of Medicine, Head of the Department of Neonatology and Pediatrics; Professor of the Department of Neonatology
P. Shmakov
National Medical Research Center of Obstetrics, Gynecology, and Perinatology named after V.I. Kulakov; Federal State Autonomous Educational Institution of Higher Education, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russia
Email: r_shmakov@oparina4.ru
Doctor of Medicine, Head Physician
参考
- Liu Y., Y. Liu, Wang Y., Chen X., Chen H., Zhang J. Malignancies associated with pregnancy: an analysis of 21 clinical cases. Irish. J. Med. Sci. 2015; 184(1): 175-81.
- Pavlidis N. Cancer and pregnancy: what should we know about the management with systemic treatment of pregnant women with cancer? Eur. J. Cancer. 2011; 47(Suppl. 3): S348-52.
- Паукер В.А., Шмаков Р.Г. Онкологические заболевания и беременность. Акушерство и гинекология. 2013; 11: 13-8. [Pauker W.A., Shmakov R.G. Cancer and pregnancy. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2013; (11): 13-8. (in Russian)]
- Cordoba O., Llurba E., Saura C., Rubio I., Ferrer Q., Cortés J., Xercavins J. Multidisciplinary approach to breast cancer diagnosed during pregnancy: Maternal and neonatal outcomes. Breast. 2013; 22(4): 515-9.
- Ko E.M., Van Le L. Chemotherapy for gynecologic cancers occurring during pregnancy. Obstet. Gynecol. Surv. 2011; 66(5): 291-8.
- Vandenbriele C., Dierickx D., Amant F., Delforge M. The treatment of hematologic malignancies in pregnancy. Facts Views Vis. Obgyn. 2010; 2(2): 74-87.
- Cordoba O., Llurba E., Cortés J., Sabadell M.D., Lirola J.L., Ferrer Q. et al. Complete pathological remission in a patient with hormonereceptor positive and c-erbB-2 expression-negative breast cancer treated with FAC chemotherapy during pregnancy. Tumori. 2010; 96(4): 629-32.
- Brewer M., Kueck A., Runowicz C.D. Chemotherapy in pregnancy. Clin. Obstet. Gynecol. 2011; 54(4): 602-18.
- Ives A.D., Saunders C.M., Semmens J.B. The Western Australian gestational breast cancer project: a population-based study of the incidence, management and outcomes. Breast. 2005; 14(4): 276-82.
- Hahn K.M., Johnson P.H., Gordon N., Kuerer H., Middleton L., Ramirez M. et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer. 2006; 107(6): 1219-26.
- Murthy R.K., Theriault R.L., Barnett C.M., Hodge S., Ramirez M.M., Milbourne A. et al. Outcomes of children exposed in utero to chemotherapy for breast cancer. Breast Cancer Res. 2014; 16(6): 500.
- Волочаева М.В., Шмаков Р.Г., Зубков В.В. Здоровье детей, рожденных женщинами с раком молочной железы, связанным с беременностью. Акушерство и гинекология. 2014; 7: 33-7. [Volochaeva M.V., Shmakov R.G., Zubkov V.V. The health of babies born to women with pregnancy-associated breast cancer. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2014; (7): 33-7. (in Russian)]
- Fenton T.R., Nasser R., Eliasziw M., Kim J.H., Bilan D., Sauve R. Validating the weight gain of preterm infants between the reference growth curve of the fetus and the term infant. BMC Pediatr. 2013; 13: 92.
- Motta M., Ciardelli L., Marconi M., Tincani A., Gasparoni A., Lojacono A., Chirico G. Immune system development in infants born to mothers with autoimmune disease, exposed in utero to immunosuppressive agents. Am. J. Perinatol. 2007; 24(8): 441-7.